Neurogene : ASGCT NGN-401 Clinical Safety Poster
Preliminary Safety Results from the Ph1/2 Study of NGN-401, a Novel Regulated Gene Therapy for Rett Syndrome Suter B1, Lieberman D2, Benke T3,...
Source: marketscreener.com
Global Impression News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Global Impression. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Global Impression Today - Breaking & Trending Today
Annovis Bio Announces Statistically Significant Phase II/III Data in Patients With Early Alzheimer's Disease
Significantly higher rate of improvement in ADAS-Cog 11 scores in each treatment dose relative to placebo for patients with mild ADImprovement in cognition measured by ADAS-Cog 11 at three months is...
Source: marketscreener.com
Hidradenitis Suppurativa: Sonelokimab Shows Promise in Study
Sonelokimab is a novel humanized nanobody that selectively binds to interleukin (IL)-17A and IL-17F.
Source: medscape.com
CervoMed Announces Appointment of Industry Leader Joshua Boger, Ph.D., as Chair of the Board - CervoMed (NASDAQ:CRVO)
Dr. Boger is the founder, and retired CEO and Board Chair, of Vertex Pharmaceuticals CervoMed on track to complete enrollment in 1H 2024 in its RewinD-LB Phase 2b clinical trial evaluating neflamapimod in patients with
Source: benzinga.com
Inozyme Pharma Reports Third Quarter 2023 Financial Results and Provides Business Highlights
– Patient recruitment underway in ENERGY-3 Pivotal Trial of INZ-701 in pediatric patients with ENPP1 Deficiency; topline data expected mid-2025 –
Source: eagletribune.com